Author, year | Drug | N, Tx/control | Study country | Centre | Study design | Author, year | Drug | N, Tx/control | Study country | Centre | Study design | Author, year | Drug | N, Tx/ control | Study country | Centre | Study design |
Balkhair et al, 202026 | A | 45/24 | Oman | Single centre | Prospective with control | Roumier et al, 202032 | T | 49/47 | France | Single centre | Prospective with control | Kimmig et al, 202033 | T | 54/57 | USA | Single centre | Retrospective |
Huet et al, 202029 | A | 52/44 | France | Single centre | Prospective with control | Salama et al, 202022 | T | 249/ 128 | USA | Multicentre | Double-blind RCT | Klopfenstein et al, 202034 | T | 20/25 | France | Single centre | Retrospective |
Kooistra et al, 202035 | A | 21/39 | Netherlands | Multicentre | Prospective with control | Salvarani et al, 202036 | T | 60/63 | Italy | Multicentre | Open-label RCT | Lewis et al, 202037 | T | 497/497 | USA | Multicentre | Retrospective |
*Kyriazopoulou et al, 202028 | A | 130/130 | Greece | Multicentre | Prospective | *Sanchez-Montalva et al, 202038 | T | 82/0 | Spain | Single centre | Prospective | Martinez-Sanz et al, 202039 | T | 260/969 | Spain | Multicentre | Retrospective |
Cauchois et al, 202024 | A | 12/10 | France | Multicentre | Retrospective | Sciascia et al, 202040 | T | 63/0 | Italy | Multicentre | Prospective | Narain et al, 202027 | T | 73/3076 | USA | Multicentre | Retrospective |
Cavalli et al, 202025 | A | 29/16 | Italy | Single centre | Retrospective | Stone et al, 202021 | T | 161/ 82 | USA | Multicentre | Double-blind RCT | Nasa et al, 202041 | T | 22/63 | India | Multicentre | Retrospective |
Narain et al, 202027 | A | 57/3076 | USA | Multicentre | Retrospective | Strohbehn et al, 202042 | T | 32/41 | USA | Single centre | Phase II open label | Patel et al, 202043 | T | 60/1505 | USA | Single centre | Retrospective |
Benucci et al, 202044 | Sa | 8/0 | Italy | Single centre | Prospective | Toniati et al, 202045 | T | 100/0 | Italy | Single centre | Prospective | *Petrak et al, 202046 | T | 81/37 | USA | Multicentre | Retrospective |
Della-Torre et al, 202030 | Sa | 28/28 | Italy | Single centre | Prospective with control | Biran et al, 202047 | T | 210/ 420 | USA | Multicentre | Retrospective | Pettit et al, 202048 | T | 42/41 | USA | Single centre | Retrospective |
*Gordon et al, 202120 | Sa | 45/397 | UK | Multicentre | Adaptive RCT | Canziani et al, 202049 | T | 64/64 | Italy | Multicentre | Retrospective | Potere et al, 202050 | T | 74/74 | Italy | Single centre | Retrospective |
Gremese et al, 202051 | Sa | 53/0 | Italy | Single centre | Prospective | Capra et al, 202052 | T | 62/23 | Italy | Single centre | Retrospective | *Ramaswamy et al, 202053 | T | 10/10 | USA | Multicentre | Retrospective |
Sinha et al, 202054 | Sa | 255/0 | USA | Single centre | Prospective | Chilimuri et al, 202055 | T | 83/ 685 | USA | Single centre | Retrospective | Rodríguez-Baño et al, 202056 | T | 21/65 | Spain | Multicentre | Retrospective |
*Gritti et al, 202031 | Si | 30/30 | Italy | Single centre | Prospective with control | De Rossi et al, 202057 | T | 90/68 | Italy | Single centre | Retrospective | Rojas-Marte et al, 202058 | T | 88/344 | USA | Single centre | Retrospective |
Albertini et al, 202059 | T | 22/22 | France | Single centre | Prospective with control | Eimer et al, 202060 | T | 22/22 | Sweden | Single centre | Retrospective | Roomi et al, 202061 | T | 96/97 | USA | Single centre | Retrospective |
Antony et al, 202062 | T | 80/0 | USA | Multicentre | Prospective | Fisher et al, 202063 | T | 45/70 | USA | Single centre | Retrospective | Rosas et al, 202064 | T | 20/17 | Spain | Single centre | Retrospective |
Campins et al, 202065 | T | 58/0 | Spain | Single centre | Prospective | Galván-Román et al, 202066 | T | 58/88 | Spain | Single centre | Retrospective | Rossi et al, 202067 | T | 84/84 | France | Single centre | Retrospective |
*Carvalho et al, 202068 | T | 29/24 | Brazil | Single centre | Prospective with control | *Moreno Garcia et al, 202069 | T | 77/94 | Spain | Single centre | Retrospective | Rossotti et al, 202070 | T | 74/148 | Italy | Single centre | Retrospective |
Dastan et al, 202071 | T | 42/0 | Iran | Single centre | Prospective | Gokhale et al, 202072 | T | 70/91 | India | Single centre | Retrospective | Ruiz-Antorán et al, 202073 | T | 268/238 | Spain | Multicentre | Retrospective |
*Gordon et al, 202120 | T | 350/397 | UK | Multicentre | Adaptive RCT | Guaraldi et al, 202074 | T | 179/ 365 | Italy | Multicentre | Retrospective | Somers et al, 202075 | T | 78/76 | USA | Single centre | Retrospective |
Hermine et al, 202023 | T | 63/67 | France | Multicentre | Open-label RCT | Guisado-Vasco et al, 202076 | T | 132/ 475 | Spain | Single centre | Retrospective | Tian et al, 202077 | T | 65/130 | China | Multicentre | Retrospective |
Malekzadeh et al, 202078 | T | 126/0 | Iran | Multicentre | Prospective | Gupta et al, 202079 | T | 433/ 3492 | USA | Multicentre | Retrospective | Tsai et al, 202080 | T | 66/66 | USA | Single centre | Retrospective |
Mikulska et al, 202081 | T | 29/66 | Italy | Single centre | Prospective with control | Hill et al, 202082 | T | 43/45 | USA | Single centre | Retrospective | *Wadud et al, 202083 | T | 84/84 | USA | Single centre | Retrospective |
Morena et al, 202084 | T | 51/0 | Italy | Single centre | Prospective | Holt et al, 202085 | T | 24/30 | USA | Single centre | Retrospective | Zheng et al, 202086 | T | 92/89 | China | Single centre | Retrospective |
Perrone et al, 202087 | T | 708/481 | Italy | Multicentre | Single-arm open label and validation | Ip et al, 202088 | T | 134/413 | USA | Multicentre | Retrospective | ||||||
*Rosas et al, 202089 | T | 294/144 | USA | Multicentre | Double-blind RCT | Kewan et al, 202090 | T | 28/23 | USA | Single centre | Retrospective |
*Non-peer-reviewed preprint study.
A, anakinra; RCT, randomised clinical trial; Sa, sarilumab; Si, siltuximab; T, tocilizumab.